5.9k Share this

However, the study authors said that adding the fourth dose for people inoculated and boostered with the Pfizer-BioNTech shot may only have “marginal benefits”.

They added: “Our cohort was too small to allow for accurate determination of vaccine efficacy.

“However, within the wide confidence intervals of our estimates, vaccine efficacy against symptomatic disease was 65 percent at most.”

It comes as coronavirus cases have surged across the country, with infections among over-70s reaching record highs.

Source: Daily Express

5.9k Share this
You May Also Like

The end of cataract surgery? Experts say vision-robbing condition may soon be treated with DRUGS

The end of cataract surgery? Experts say vision-robbing condition may soon be…

Supplement caution: St John’s Wort can interfere with common prescription drugs

SUPPLEMENTS can play a useful role in strengthening the immune system and…

Dr MEGAN ROSSI: The simple quiz to get you on track to a happy gut!

You’re told to ‘go with your gut’. You might say you feel…

FDA approves COVID-19 booster shots for children five to 11 years old

Children aged five to 11 years old can now get a booster…

325,000 are living with undiagnosed dementia as report bemoans postcode lottery

More than 325,000 people are living with dementia in England – but…

Long Covid: Trouble focusing and brain fog are among the surprising signs

There is also some suggestion that a vaccine can help reduce long…

NHS will NOT hit key cancer targets by next March, health chief warns

Dr Liz Bishop (pictured), who sits on NHS England’s national cancer board,…

75% of sunscreens either do not provide proper protection or have dangerous chemicals

A majority of sunscreens available in the United States are not meeting…